Indication

Adverse Drug Event

14 clinical trials

18 products

2 drugs

Product
Insulin
Product
SHINGRIX®
Clinical trial
Melatonin for the Prevention of Antibiotic Associated Acute Kidney Injury
Status: Recruiting, Estimated PCD: 2026-06-01
Product
Melatonin
Clinical trial
Oncolytic Virus Ad-TD-nsIL12 for Primary Pediatric Diffuse Intrinsic Pontine Glioma
Status: Recruiting, Estimated PCD: 2025-01-04
Product
SPC-flakes
Product
IIV4
Product
Salovum
Product
Opioid
Clinical trial
Oncolytic Virus Ad-TD-nsIL12 for Progressive Pediatric Diffuse Intrinsic Pontine Glioma
Status: Recruiting, Estimated PCD: 2025-01-04
Clinical trial
Adoptive TIL Therapy With Low-dose IFN-alpha Plus Anti-PD1 in Metastatic Melanoma
Status: Active (not recruiting), Estimated PCD: 2025-11-29
Clinical trial
Monitoring the Antiphospholipid Syndrome:TOXicity of Drugs (APSTOX)
Status: Completed, Estimated PCD: 2021-06-30
Clinical trial
Monitoring the Hyperammonaemia:TOXicity of Drugs (AmmoTOX)
Status: Completed, Estimated PCD: 2020-05-30